This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Dec 2;385(23):2201.

doi: 10.1056/NEJMc2115772.

Mycophenolate Mofetil for Immune Thrombocytopenia

Wobke E M van Dijk¹, Roger E G Schutgens¹

Affiliations

PMID: 34874643
DOI: 10.1056/NEJMc2115772

Comment

Mycophenolate Mofetil for Immune Thrombocytopenia

Wobke E M van Dijk et al. N Engl J Med. 2021.

. 2021 Dec 2;385(23):2201.

doi: 10.1056/NEJMc2115772.

Authors

Wobke E M van Dijk¹, Roger E G Schutgens¹

Affiliation

¹ University Medical Center Utrecht, Utrecht, the Netherlands w.e.m.vandijk-16@umcutrecht.nl.

PMID: 34874643
DOI: 10.1056/NEJMc2115772

No abstract available

PubMed Disclaimer

Comment in

Mycophenolate Mofetil for Immune Thrombocytopenia. Reply.
Bradbury CA, Hill Q, Greenwood R. Bradbury CA, et al. N Engl J Med. 2021 Dec 2;385(23):2201-2202. doi: 10.1056/NEJMc2115772. N Engl J Med. 2021. PMID: 34874644 No abstract available.

Comment on

Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia.
Bradbury CA, Pell J, Hill Q, Bagot C, Cooper N, Ingram J, Breheny K, Kandiyali R, Rayment R, Evans G, Talks K, Thomas I, Greenwood R. Bradbury CA, et al. N Engl J Med. 2021 Sep 2;385(10):885-895. doi: 10.1056/NEJMoa2100596. N Engl J Med. 2021. PMID: 34469646 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.